Total Payments
$246,940
2024 Payments
$563.87
Companies
19
Transactions
436
Medicare Patients
37,524
Medicare Billing
$2.4M
Payment Breakdown by Category
Other$189,800 (76.9%)
Travel$23,403 (9.5%)
Consulting$21,460 (8.7%)
Food & Beverage$12,221 (4.9%)
Education$56.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $187,240 | 72 | 75.8% |
| Travel and Lodging | $23,403 | 88 | 9.5% |
| Consulting Fee | $21,460 | 6 | 8.7% |
| Food and Beverage | $12,221 | 263 | 4.9% |
| Honoraria | $2,560 | 1 | 1.0% |
| Education | $56.42 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $142,652 | 196 | $0 (2024) |
| Gilead Sciences, Inc. | $99,312 | 179 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $3,586 | 8 | $0 (2023) |
| Boston Scientific Corporation | $192.70 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $173.51 | 12 | $0 (2024) |
| Daiichi Sankyo Inc. | $172.17 | 5 | $0 (2022) |
| Celgene Corporation | $143.20 | 9 | $0 (2024) |
| Perspectum Diagnostics Ltd | $123.35 | 1 | $0 (2023) |
| UCB, Inc. | $121.94 | 3 | $0 (2019) |
| Romark Laboratories, LC | $105.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $563.87 | 21 | Gilead Sciences, Inc. ($257.23) |
| 2023 | $866.52 | 28 | Gilead Sciences, Inc. ($397.38) |
| 2022 | $1,033 | 35 | Gilead Sciences, Inc. ($444.96) |
| 2021 | $4,704 | 22 | AbbVie Inc. ($2,636) |
| 2020 | $16,468 | 32 | Gilead Sciences, Inc. ($8,473) |
| 2019 | $75,302 | 92 | AbbVie, Inc. ($56,743) |
| 2018 | $77,180 | 98 | AbbVie, Inc. ($40,962) |
| 2017 | $70,823 | 108 | AbbVie, Inc. ($33,817) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.71 | General |
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $140.78 | General |
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Immunology | ||||||
| 10/29/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/28/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.19 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2024 | ERBE USA INC | Vio3 (Device) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: ELECTROSURGICAL | ||||||
| 03/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.04 | General |
| 03/07/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $87.51 | General |
| 11/15/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Immunology | ||||||
| 11/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: Neuroscience | ||||||
| 11/12/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $109.14 | General |
| 11/06/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.70 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 8,129 | 15,575 | $3.6M | $633,609 |
| 2022 | 39 | 8,242 | 15,001 | $3.2M | $610,146 |
| 2021 | 50 | 10,388 | 16,305 | $3.2M | $610,404 |
| 2020 | 53 | 10,765 | 16,272 | $3.5M | $565,100 |
Total Patients
37,524
Total Services
63,153
Medicare Billing
$2.4M
Procedure Codes
172
All Medicare Procedures & Services
172 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 1,865 | 3,717 | $985,635 | $181,412 | 18.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 3,294 | 7,670 | $1.0M | $180,054 | 17.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 1,647 | 2,044 | $663,900 | $122,639 | 18.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 85 | 85 | $96,780 | $17,146 | 17.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 192 | 197 | $123,920 | $15,335 | 12.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 216 | 259 | $86,771 | $13,815 | 15.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 113 | 113 | $101,272 | $10,975 | 10.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 39 | 205 | $48,836 | $9,391 | 19.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 36 | 241 | $45,081 | $8,399 | 18.6% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 105 | 105 | $40,884 | $7,711 | 18.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 42 | 42 | $34,968 | $7,390 | 21.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2023 | 42 | 42 | $33,168 | $6,059 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 61 | $24,590 | $5,243 | 21.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 24 | 145 | $30,411 | $5,124 | 16.9% |
| 49082 | Drainage of fluid from abdominal cavity | Facility | 2023 | 16 | 90 | $29,795 | $4,699 | 15.8% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 48 | $24,097 | $4,655 | 19.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 25 | 25 | $20,666 | $4,353 | 21.1% |
| 43244 | Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | Facility | 2023 | 15 | 19 | $19,746 | $3,541 | 17.9% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 66 | $17,204 | $3,501 | 20.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $13,838 | $3,142 | 22.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 18 | 83 | $17,534 | $2,890 | 16.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 21 | $17,304 | $2,879 | 16.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $13,716 | $2,354 | 17.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 39 | $11,133 | $2,277 | 20.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 20 | 81 | $14,053 | $2,191 | 15.6% |
About Dr. David Dies, M.D
Dr. David Dies, M.D is a Gastroenterology healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205826419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dies, M.D has received a total of $246,940 in payments from pharmaceutical and medical device companies, with $563.87 received in 2024. These payments were reported across 436 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($187,240).
As a Medicare-enrolled provider, Dies has provided services to 37,524 Medicare beneficiaries, totaling 63,153 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 172 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Transplant Hepatology
- Location Shreveport, LA
- Active Since 10/27/2005
- Last Updated 08/11/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1205826419
Products in Payments
- Mavyret (Drug) $105,535
- Epclusa (Drug) $74,126
- Viekira (Drug) $21,934
- Vosevi (Drug) $10,395
- MAVYRET (Drug) $8,991
- OCA (Drug) $3,557
- Vemlidy (Drug) $3,480
- RINVOQ (Biological) $209.92
- INJECTAFER (Drug) $164.56
- HUMIRA (Biological) $163.12
- ZEPOSIA (Drug) $143.20
- LINZESS (Drug) $131.51
- LiverMultiScan (Device) $123.35
- ENTYVIO (Biological) $119.01
- Alinia Tablets 500mg 30 count bottle (Drug) $105.39
- Acquire (Device) $105.09
- SKYRIZI (Biological) $103.41
- DUPIXENT (Biological) $91.24
- EXALT Model D (Device) $76.12
- XIFAXAN (Drug) $61.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Shreveport
Sathya Jaganmohan, M.d, M.D
Gastroenterology — Payments: $65,914
Gastroenterology $65,914
John Provenza, M.d, M.D
Gastroenterology — Payments: $10,336
Gastroenterology $10,336
David Scott, M.d, M.D
Gastroenterology — Payments: $9,305
Gastroenterology $9,305
Dr. John Kirkikis, Md, MD
Gastroenterology — Payments: $6,909
Gastroenterology $6,909
Paul Jordan, M.d, M.D
Gastroenterology — Payments: $4,896
Gastroenterology $4,896
James Hobley, M.d, M.D
Gastroenterology — Payments: $4,422
Gastroenterology $4,422